Simply wall street mrna：Investors might be losing patience for Moderna's (NASDAQ ...
Investors might be losing patience for Moderna's (NASDAQ ...
2024年9月13日—SomeModerna,Inc.(NASDAQ:MRNA)shareholdersareprobablyratherconcernedtoseethesharepricefall50%overthelastthreemonths.。其他文章還包含有：「Moderna(BASE:MRNA)」、「Moderna(BVL:MRNA)」、「Moderna(MRNA)BalanceSheet&FinancialHealthMetrics」、「Moderna(Nasdaq:MRNA)」、「Moderna(NasdaqGS」、「Moderna(NasdaqGS」、「Moderna(NasdaqGS」、「Moderna」
查看更多 離開網站
Moderna (BASE:MRNA)
https://simplywall.st
Moderna BASE:MRNA Stock Report ; 52 Week High, US$11,150.00 ; 52 Week Low, US$5,410.00 ; Beta, 1.66 ; 11 Month Change, -31.53% ; 3 Month Change, -48.27%.
Moderna (BVL:MRNA)
https://simplywall.st
Research Moderna's (BVL:MRNA) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.
Moderna (MRNA) Balance Sheet & Financial Health Metrics
https://simplywall.st
Discover Moderna's balance sheet and financial health metrics. From total debt, total equity, assets to cash-on-hand, interest coverage and more.
Moderna (Nasdaq:MRNA)
https://simplywall.st
Research Moderna's (Nasdaq:MRNA) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.
Moderna (NasdaqGS
https://simplywall.st
Moderna's earnings have been declining at an average annual rate of -2.3%, while the Biotechs industry saw earnings growing at 19.1% annually.
Moderna (NasdaqGS
https://simplywall.st
Revenue vs Market: MRNA's revenue (12.1% per year) is forecast to grow faster than the US market (8.7% per year).
Moderna (NasdaqGS
https://simplywall.st
Price-To-Sales vs Industry: MRNA is good value based on its Price-To-Sales Ratio (5.1x) compared to the US Biotechs industry average (12.3x).
Moderna
https://simplywall.st
Name: Moderna, Inc. · Ticker: MRNA · Exchange: WBAG · Founded: 2010 · Industry: Biotechnology · Sector: Pharmaceuticals & Biotech · Market Cap: US$58.057b · Listing ...